Buras Andrea L, Chern Jing Yi, Chon Hye Sook, Shahzad Mian M, Wenham Robert M, Hoffman Mitchel S
Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Gynecol Oncol Rep. 2021 Jun 25;37:100815. doi: 10.1016/j.gore.2021.100815. eCollection 2021 Aug.
Vascular injury during major gynecologic cancer surgery is a rare but potentially fatal complication. The purpose of this study was to review our experience with major vascular injury during gynecologic cancer surgery.
This was a retrospective chart review of women undergoing surgery by our gynecologic oncology department from 7/1/99 to 6/30/20 who had a major vascular injury. We identified women who sustained a vascular injury by a combination of CPT code and medical record searches, fellow case logs and a list maintained for an ongoing quality assurance program. Data were expressed as median and range for continuous variables and as frequency and percentage for categorical variables. Fisher's exact test was used to analyze differences in complication rates between groups.
Major vascular injury was identified in 52 patients and procedures. The inferior vena cava was the most common site of injury, 32.7% (17/52), followed by the external iliac vein, 23.1% (12/52). Lymph node dissection was the most common time for a vascular injury to occur 51.9% (27/52). The majority of injuries required suture repair, 80.8% (42/52). Estimated blood loss in cases with vascular injury ranged from 100 mL to massive unquantifiable blood loss in the case of an aortic injury. Patients required a median of 2units of packed red blood cells. Postoperative complications included anemia requiring blood transfusion, 19.6% (9/46) and venous thromboembolism, 19.6% (9/46).
Vascular injury remains a rare but potentially morbid complication of gynecologic oncologic surgery. Prompt recognition and management are imperative in minimizing persistent bleeding and complications.
妇科癌症大手术期间的血管损伤是一种罕见但可能致命的并发症。本研究的目的是回顾我们在妇科癌症手术期间处理重大血管损伤的经验。
这是一项对1999年7月1日至2020年6月30日期间在我们妇科肿瘤科室接受手术且发生重大血管损伤的女性患者进行的回顾性病历审查。我们通过CPT编码和病历搜索、同事的病例记录以及为正在进行的质量保证计划维护的列表相结合的方式,确定发生血管损伤的女性患者。连续变量的数据以中位数和范围表示,分类变量的数据以频率和百分比表示。采用Fisher精确检验分析组间并发症发生率的差异。
在52例患者和手术中发现了重大血管损伤。下腔静脉是最常见的损伤部位,占32.7%(17/52),其次是髂外静脉,占23.1%(12/52)。淋巴结清扫是血管损伤最常发生的时间,占51.9%(27/52)。大多数损伤需要缝合修复,占80.8%(42/52)。血管损伤病例的估计失血量从100毫升到主动脉损伤时大量无法量化的失血不等。患者平均需要2单位浓缩红细胞。术后并发症包括需要输血的贫血,占19.6%(9/46)和静脉血栓栓塞,占19.6%(9/46)。
血管损伤仍然是妇科肿瘤手术中一种罕见但可能导致发病的并发症。及时识别和处理对于将持续出血和并发症降至最低至关重要。